Anticancer agent 273

CAT:
931-T206951-01
Size:
10 mg
  • Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
  • Dry Ice Shipment: No
Anticancer agent 273 - image 1

Anticancer agent 273

  • Target :

    Apoptosis|||Akt|||PI3K
  • Related Pathways :

    PI3K/Akt/mTOR signaling|||Cytoskeletal Signaling|||Apoptosis
  • Bioactivity :

    Anticanceragent 273 (Compound 9q) is an effective anticancer compound identified from matrine. It inhibits cancer cell proliferation, with an IC50 of 4.48 ?M against HeLa cells. Anticanceragent 273 exerts its anticancer effects by modulating PI3K/AKT expression and activating activating transcription factor 4 (ATF4), which induces endoplasmic reticulum stress and triggers apoptosis. It holds potential for cancer research, including cervical cancer.
  • Shipping Conditions :

    Cool pack
  • Storage Temperature :

    -20°C

Featured Selection

Popular Products

Discover our most sought-after biotechnology products, trusted by researchers worldwide